Foghorn Therapeutics Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate, and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Foghorn Therapeutics Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Foghorn Therapeutics Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Foghorn Therapeutics Inc. is FHTX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Foghorn Therapeutics Inc. has its primary listing on NASDAQ. You can trade Foghorn Therapeutics Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Foghorn Therapeutics Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Foghorn Therapeutics Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Foghorn Therapeutics Inc..